Literature DB >> 9139465

[The Austrian Metabolic Register].

S Fang-Kircher1.   

Abstract

The "Austrian Register for Metabolic Disorders" was founded in 1995 on the initiative of the "Work Group for Congenital Metabolic Disorders" within the Austrian Society for Pediatrics. It is designed as a clearinghouse for reporting and recording congenital metabolic disorders and aims to determine the frequency and regional distribution of these diseases. Another objective is to have patient data handy if and when new therapeutic options or new means of diagnostic verification, including carrier status or prenatal diagnosis, become available. Currently more than 400 patients are on record with disorders of amino acid, organic acid, lipid or carbohydrate metabolism, as well as disorders of the mitochondria, peroxisomes and lysosomes; furthermore, dyschromia, porphyria and diseases of connective tissue and disturbances in the metabolism of purines, pyrimidines, metals or vitamins. Lysosomal enzyme defects, mitochondrial and peroxisomal disorders account for the majority of cases. Patients have to be reported on a continuous basis as prerequisite for this initiative to be successful. It is, therefore, planned to incorporate reporting of metabolic disorders to the "Register" on a national scale as integral part of the diagnosis of these conditions.

Entities:  

Mesh:

Year:  1997        PMID: 9139465

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  1 in total

1.  100 years of inherited metabolic disorders in Austria-A national registry of minimal birth prevalence, diagnosis, and clinical outcome of inborn errors of metabolism in Austria between 1921 and 2021.

Authors:  Gabriele Ramoser; Federica Caferri; Bernhard Radlinger; Michaela Brunner-Krainz; Sybille Herbst; Martina Huemer; Miriam Hufgard-Leitner; Susanne G Kircher; Vassiliki Konstantopoulou; Wolfgang Löscher; Dorothea Möslinger; Barbara Plecko; Johannes Spenger; Thomas Stulnig; Gere Sunder-Plassmann; Saskia Wortmann; Sabine Scholl-Bürgi; Daniela Karall
Journal:  J Inherit Metab Dis       Date:  2021-10-17       Impact factor: 4.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.